The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Retrovirus-Based Gene Therapy Drugs Market Research Report 2025
Synopsis
Retrovirus-based gene therapy drugs are drugs that use retroviruses as vectors to introduce normal or modified genes into patient cells to treat genetic diseases, cancer and other diseases. Retroviruses occur naturally in some animals and can reverse-transcribe RNA into DNA and insert into the genome of host cells. In gene therapy, scientists take advantage of this feature to load therapeutic genes into retroviral vectors, allowing them to enter the patient's cells and express the required proteins to achieve therapeutic purposes.
The global Retrovirus-Based Gene Therapy Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Retrovirus-Based Gene Therapy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Retrovirus-Based Gene Therapy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Retrovirus-Based Gene Therapy Drugs in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Retrovirus-Based Gene Therapy Drugs include GSK, Chaselection, MolMed, GILD, Denovo Biopharma, Pfizer, Epeius, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Retrovirus-Based Gene Therapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retrovirus-Based Gene Therapy Drugs.
The Retrovirus-Based Gene Therapy Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Retrovirus-Based Gene Therapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Retrovirus-Based Gene Therapy Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Chaselection
MolMed
GILD
Denovo Biopharma
Pfizer
Epeius
Segment by Type
CAR-T Therapy
Autologous CD34+ Cell Gene Therapy
Segment by Application
Hospital
Diagnostic and Testing Laboratories
Academic and Research Organizations
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Retrovirus-Based Gene Therapy Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Retrovirus-based gene therapy drugs are drugs that use retroviruses as vectors to introduce normal or modified genes into patient cells to treat genetic diseases, cancer and other diseases. Retroviruses occur naturally in some animals and can reverse-transcribe RNA into DNA and insert into the genome of host cells. In gene therapy, scientists take advantage of this feature to load therapeutic genes into retroviral vectors, allowing them to enter the patient's cells and express the required proteins to achieve therapeutic purposes.
The global Retrovirus-Based Gene Therapy Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Retrovirus-Based Gene Therapy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Retrovirus-Based Gene Therapy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Retrovirus-Based Gene Therapy Drugs in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Retrovirus-Based Gene Therapy Drugs include GSK, Chaselection, MolMed, GILD, Denovo Biopharma, Pfizer, Epeius, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Retrovirus-Based Gene Therapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retrovirus-Based Gene Therapy Drugs.
The Retrovirus-Based Gene Therapy Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Retrovirus-Based Gene Therapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Retrovirus-Based Gene Therapy Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Chaselection
MolMed
GILD
Denovo Biopharma
Pfizer
Epeius
Segment by Type
CAR-T Therapy
Autologous CD34+ Cell Gene Therapy
Segment by Application
Hospital
Diagnostic and Testing Laboratories
Academic and Research Organizations
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Retrovirus-Based Gene Therapy Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retrovirus-Based Gene Therapy Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CAR-T Therapy
1.2.3 Autologous CD34+ Cell Gene Therapy
1.3 Market by Application
1.3.1 Global Retrovirus-Based Gene Therapy Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Diagnostic and Testing Laboratories
1.3.4 Academic and Research Organizations
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Retrovirus-Based Gene Therapy Drugs Market Perspective (2019-2030)
2.2 Global Retrovirus-Based Gene Therapy Drugs Growth Trends by Region
2.2.1 Global Retrovirus-Based Gene Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Retrovirus-Based Gene Therapy Drugs Historic Market Size by Region (2019-2024)
2.2.3 Retrovirus-Based Gene Therapy Drugs Forecasted Market Size by Region (2025-2030)
2.3 Retrovirus-Based Gene Therapy Drugs Market Dynamics
2.3.1 Retrovirus-Based Gene Therapy Drugs Industry Trends
2.3.2 Retrovirus-Based Gene Therapy Drugs Market Drivers
2.3.3 Retrovirus-Based Gene Therapy Drugs Market Challenges
2.3.4 Retrovirus-Based Gene Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retrovirus-Based Gene Therapy Drugs Players by Revenue
3.1.1 Global Top Retrovirus-Based Gene Therapy Drugs Players by Revenue (2019-2024)
3.1.2 Global Retrovirus-Based Gene Therapy Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Retrovirus-Based Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Retrovirus-Based Gene Therapy Drugs Revenue
3.4 Global Retrovirus-Based Gene Therapy Drugs Market Concentration Ratio
3.4.1 Global Retrovirus-Based Gene Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retrovirus-Based Gene Therapy Drugs Revenue in 2023
3.5 Global Key Players of Retrovirus-Based Gene Therapy Drugs Head office and Area Served
3.6 Global Key Players of Retrovirus-Based Gene Therapy Drugs, Product and Application
3.7 Global Key Players of Retrovirus-Based Gene Therapy Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Retrovirus-Based Gene Therapy Drugs Breakdown Data by Type
4.1 Global Retrovirus-Based Gene Therapy Drugs Historic Market Size by Type (2019-2024)
4.2 Global Retrovirus-Based Gene Therapy Drugs Forecasted Market Size by Type (2025-2030)
5 Retrovirus-Based Gene Therapy Drugs Breakdown Data by Application
5.1 Global Retrovirus-Based Gene Therapy Drugs Historic Market Size by Application (2019-2024)
5.2 Global Retrovirus-Based Gene Therapy Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Retrovirus-Based Gene Therapy Drugs Market Size (2019-2030)
6.2 North America Retrovirus-Based Gene Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Retrovirus-Based Gene Therapy Drugs Market Size by Country (2019-2024)
6.4 North America Retrovirus-Based Gene Therapy Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Retrovirus-Based Gene Therapy Drugs Market Size (2019-2030)
7.2 Europe Retrovirus-Based Gene Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Retrovirus-Based Gene Therapy Drugs Market Size by Country (2019-2024)
7.4 Europe Retrovirus-Based Gene Therapy Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Retrovirus-Based Gene Therapy Drugs Market Size (2019-2030)
8.2 Asia-Pacific Retrovirus-Based Gene Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Retrovirus-Based Gene Therapy Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Retrovirus-Based Gene Therapy Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Retrovirus-Based Gene Therapy Drugs Market Size (2019-2030)
9.2 Latin America Retrovirus-Based Gene Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Retrovirus-Based Gene Therapy Drugs Market Size by Country (2019-2024)
9.4 Latin America Retrovirus-Based Gene Therapy Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size (2019-2030)
10.2 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Retrovirus-Based Gene Therapy Drugs Introduction
11.1.4 GSK Revenue in Retrovirus-Based Gene Therapy Drugs Business (2019-2024)
11.1.5 GSK Recent Development
11.2 Chaselection
11.2.1 Chaselection Company Details
11.2.2 Chaselection Business Overview
11.2.3 Chaselection Retrovirus-Based Gene Therapy Drugs Introduction
11.2.4 Chaselection Revenue in Retrovirus-Based Gene Therapy Drugs Business (2019-2024)
11.2.5 Chaselection Recent Development
11.3 MolMed
11.3.1 MolMed Company Details
11.3.2 MolMed Business Overview
11.3.3 MolMed Retrovirus-Based Gene Therapy Drugs Introduction
11.3.4 MolMed Revenue in Retrovirus-Based Gene Therapy Drugs Business (2019-2024)
11.3.5 MolMed Recent Development
11.4 GILD
11.4.1 GILD Company Details
11.4.2 GILD Business Overview
11.4.3 GILD Retrovirus-Based Gene Therapy Drugs Introduction
11.4.4 GILD Revenue in Retrovirus-Based Gene Therapy Drugs Business (2019-2024)
11.4.5 GILD Recent Development
11.5 Denovo Biopharma
11.5.1 Denovo Biopharma Company Details
11.5.2 Denovo Biopharma Business Overview
11.5.3 Denovo Biopharma Retrovirus-Based Gene Therapy Drugs Introduction
11.5.4 Denovo Biopharma Revenue in Retrovirus-Based Gene Therapy Drugs Business (2019-2024)
11.5.5 Denovo Biopharma Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Retrovirus-Based Gene Therapy Drugs Introduction
11.6.4 Pfizer Revenue in Retrovirus-Based Gene Therapy Drugs Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Epeius
11.7.1 Epeius Company Details
11.7.2 Epeius Business Overview
11.7.3 Epeius Retrovirus-Based Gene Therapy Drugs Introduction
11.7.4 Epeius Revenue in Retrovirus-Based Gene Therapy Drugs Business (2019-2024)
11.7.5 Epeius Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Retrovirus-Based Gene Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of CAR-T Therapy
Table 3. Key Players of Autologous CD34+ Cell Gene Therapy
Table 4. Global Retrovirus-Based Gene Therapy Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Retrovirus-Based Gene Therapy Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Retrovirus-Based Gene Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Retrovirus-Based Gene Therapy Drugs Market Share by Region (2019-2024)
Table 8. Global Retrovirus-Based Gene Therapy Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Retrovirus-Based Gene Therapy Drugs Market Share by Region (2025-2030)
Table 10. Retrovirus-Based Gene Therapy Drugs Market Trends
Table 11. Retrovirus-Based Gene Therapy Drugs Market Drivers
Table 12. Retrovirus-Based Gene Therapy Drugs Market Challenges
Table 13. Retrovirus-Based Gene Therapy Drugs Market Restraints
Table 14. Global Retrovirus-Based Gene Therapy Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Retrovirus-Based Gene Therapy Drugs Market Share by Players (2019-2024)
Table 16. Global Top Retrovirus-Based Gene Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retrovirus-Based Gene Therapy Drugs as of 2023)
Table 17. Ranking of Global Top Retrovirus-Based Gene Therapy Drugs Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Retrovirus-Based Gene Therapy Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Retrovirus-Based Gene Therapy Drugs, Headquarters and Area Served
Table 20. Global Key Players of Retrovirus-Based Gene Therapy Drugs, Product and Application
Table 21. Global Key Players of Retrovirus-Based Gene Therapy Drugs, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Retrovirus-Based Gene Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Retrovirus-Based Gene Therapy Drugs Revenue Market Share by Type (2019-2024)
Table 25. Global Retrovirus-Based Gene Therapy Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Retrovirus-Based Gene Therapy Drugs Revenue Market Share by Type (2025-2030)
Table 27. Global Retrovirus-Based Gene Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Retrovirus-Based Gene Therapy Drugs Revenue Market Share by Application (2019-2024)
Table 29. Global Retrovirus-Based Gene Therapy Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Retrovirus-Based Gene Therapy Drugs Revenue Market Share by Application (2025-2030)
Table 31. North America Retrovirus-Based Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Retrovirus-Based Gene Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Retrovirus-Based Gene Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Retrovirus-Based Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Retrovirus-Based Gene Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Retrovirus-Based Gene Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Retrovirus-Based Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Retrovirus-Based Gene Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Retrovirus-Based Gene Therapy Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Retrovirus-Based Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Retrovirus-Based Gene Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Retrovirus-Based Gene Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. GSK Company Details
Table 47. GSK Business Overview
Table 48. GSK Retrovirus-Based Gene Therapy Drugs Product
Table 49. GSK Revenue in Retrovirus-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 50. GSK Recent Development
Table 51. Chaselection Company Details
Table 52. Chaselection Business Overview
Table 53. Chaselection Retrovirus-Based Gene Therapy Drugs Product
Table 54. Chaselection Revenue in Retrovirus-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 55. Chaselection Recent Development
Table 56. MolMed Company Details
Table 57. MolMed Business Overview
Table 58. MolMed Retrovirus-Based Gene Therapy Drugs Product
Table 59. MolMed Revenue in Retrovirus-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 60. MolMed Recent Development
Table 61. GILD Company Details
Table 62. GILD Business Overview
Table 63. GILD Retrovirus-Based Gene Therapy Drugs Product
Table 64. GILD Revenue in Retrovirus-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 65. GILD Recent Development
Table 66. Denovo Biopharma Company Details
Table 67. Denovo Biopharma Business Overview
Table 68. Denovo Biopharma Retrovirus-Based Gene Therapy Drugs Product
Table 69. Denovo Biopharma Revenue in Retrovirus-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 70. Denovo Biopharma Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Retrovirus-Based Gene Therapy Drugs Product
Table 74. Pfizer Revenue in Retrovirus-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Epeius Company Details
Table 77. Epeius Business Overview
Table 78. Epeius Retrovirus-Based Gene Therapy Drugs Product
Table 79. Epeius Revenue in Retrovirus-Based Gene Therapy Drugs Business (2019-2024) & (US$ Million)
Table 80. Epeius Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
Table 84. Authors List of This Report
List of Figures
Figure 1. Retrovirus-Based Gene Therapy Drugs Picture
Figure 2. Global Retrovirus-Based Gene Therapy Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Retrovirus-Based Gene Therapy Drugs Market Share by Type: 2023 VS 2030
Figure 4. CAR-T Therapy Features
Figure 5. Autologous CD34+ Cell Gene Therapy Features
Figure 6. Global Retrovirus-Based Gene Therapy Drugs Market Size by Application (2024-2030) & (US$ Million)
Figure 7. Global Retrovirus-Based Gene Therapy Drugs Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Diagnostic and Testing Laboratories Case Studies
Figure 10. Academic and Research Organizations Case Studies
Figure 11. Others Case Studies
Figure 12. Retrovirus-Based Gene Therapy Drugs Report Years Considered
Figure 13. Global Retrovirus-Based Gene Therapy Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Retrovirus-Based Gene Therapy Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Retrovirus-Based Gene Therapy Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Retrovirus-Based Gene Therapy Drugs Market Share by Players in 2023
Figure 17. Global Top Retrovirus-Based Gene Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retrovirus-Based Gene Therapy Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Retrovirus-Based Gene Therapy Drugs Revenue in 2023
Figure 19. North America Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Retrovirus-Based Gene Therapy Drugs Market Share by Country (2019-2030)
Figure 21. United States Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Retrovirus-Based Gene Therapy Drugs Market Share by Country (2019-2030)
Figure 25. Germany Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Retrovirus-Based Gene Therapy Drugs Market Share by Region (2019-2030)
Figure 33. China Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Retrovirus-Based Gene Therapy Drugs Market Share by Country (2019-2030)
Figure 41. Mexico Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Retrovirus-Based Gene Therapy Drugs Market Share by Country (2019-2030)
Figure 45. Turkey Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. UAE Retrovirus-Based Gene Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. GSK Revenue Growth Rate in Retrovirus-Based Gene Therapy Drugs Business (2019-2024)
Figure 49. Chaselection Revenue Growth Rate in Retrovirus-Based Gene Therapy Drugs Business (2019-2024)
Figure 50. MolMed Revenue Growth Rate in Retrovirus-Based Gene Therapy Drugs Business (2019-2024)
Figure 51. GILD Revenue Growth Rate in Retrovirus-Based Gene Therapy Drugs Business (2019-2024)
Figure 52. Denovo Biopharma Revenue Growth Rate in Retrovirus-Based Gene Therapy Drugs Business (2019-2024)
Figure 53. Pfizer Revenue Growth Rate in Retrovirus-Based Gene Therapy Drugs Business (2019-2024)
Figure 54. Epeius Revenue Growth Rate in Retrovirus-Based Gene Therapy Drugs Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
